202 related articles for article (PubMed ID: 19464034)
1. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Phytochemistry; 2009 May; 70(7):913-9. PubMed ID: 19464034
[TBL] [Abstract][Full Text] [Related]
2. Structure activity studies on the crinane alkaloid apoptosis-inducing pharmacophore.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Nat Prod Commun; 2009 Apr; 4(4):483-8. PubMed ID: 19475990
[TBL] [Abstract][Full Text] [Related]
3. In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives.
Evdokimov NM; Lamoral-Theys D; Mathieu V; Andolfi A; Frolova LV; Pelly SC; van Otterlo WA; Magedov IV; Kiss R; Evidente A; Kornienko A
Bioorg Med Chem; 2011 Dec; 19(23):7252-61. PubMed ID: 22019045
[TBL] [Abstract][Full Text] [Related]
4. Lycorine and its derivatives for anticancer drug design.
Lamoral-Theys D; Decaestecker C; Mathieu V; Dubois J; Kornienko A; Kiss R; Evidente A; Pottier L
Mini Rev Med Chem; 2010 Jan; 10(1):41-50. PubMed ID: 20105122
[TBL] [Abstract][Full Text] [Related]
5. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
Van Goietsenoven G; Andolfi A; Lallemand B; Cimmino A; Lamoral-Theys D; Gras T; Abou-Donia A; Dubois J; Lefranc F; Mathieu V; Kornienko A; Kiss R; Evidente A
J Nat Prod; 2010 Jul; 73(7):1223-7. PubMed ID: 20550100
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiplasmodial activity of lycorine derivatives.
Cedrón JC; Gutiérrez D; Flores N; Ravelo AG; Estévez-Braun A
Bioorg Med Chem; 2010 Jul; 18(13):4694-701. PubMed ID: 20627737
[TBL] [Abstract][Full Text] [Related]
7. Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids.
McNulty J; Nair JJ; Codina C; Bastida J; Pandey S; Gerasimoff J; Griffin C
Phytochemistry; 2007 Apr; 68(7):1068-74. PubMed ID: 17331551
[TBL] [Abstract][Full Text] [Related]
8. Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.
McNulty J; Nair JJ; Singh M; Crankshaw DJ; Holloway AC; Bastida J
Bioorg Med Chem Lett; 2009 Jun; 19(12):3233-7. PubMed ID: 19428250
[TBL] [Abstract][Full Text] [Related]
9. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
10. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
Lamoral-Theys D; Andolfi A; Van Goietsenoven G; Cimmino A; Le Calvé B; Wauthoz N; Mégalizzi V; Gras T; Bruyère C; Dubois J; Mathieu V; Kornienko A; Kiss R; Evidente A
J Med Chem; 2009 Oct; 52(20):6244-56. PubMed ID: 19788245
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae.
Nair JJ; Rárová L; Strnad M; Bastida J; van Staden J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6195-9. PubMed ID: 22921081
[TBL] [Abstract][Full Text] [Related]
12. Lycorine derivatives against Trichomonas vaginalis.
Giordani RB; Junior CO; de Andrade JP; Bastida J; Zuanazzi JA; Tasca T; de Almeida MV
Chem Biol Drug Des; 2012 Jul; 80(1):129-33. PubMed ID: 22260620
[TBL] [Abstract][Full Text] [Related]
13. Lycorine: A prospective natural lead for anticancer drug discovery.
Roy M; Liang L; Xiao X; Feng P; Ye M; Liu J
Biomed Pharmacother; 2018 Nov; 107():615-624. PubMed ID: 30114645
[TBL] [Abstract][Full Text] [Related]
14. The effect of Amaryllidaceae alkaloids haemanthamine and haemanthidine on cell cycle progression and apoptosis in p53-negative human leukemic Jurkat cells.
Havelek R; Seifrtova M; Kralovec K; Bruckova L; Cahlikova L; Dalecka M; Vavrova J; Rezacova M; Opletal L; Bilkova Z
Phytomedicine; 2014 Mar; 21(4):479-90. PubMed ID: 24182986
[TBL] [Abstract][Full Text] [Related]
15. Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
McNulty J; Thorat A; Vurgun N; Nair JJ; Makaji E; Crankshaw DJ; Holloway AC; Pandey S
J Nat Prod; 2011 Jan; 74(1):106-8. PubMed ID: 21105682
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity and virtual screening by molecular docking of lycorine from Pancratium foetidum Pom (Moroccan endemic Amaryllidaceae).
Bendaif H; Melhaoui A; Ramdani M; Elmsellem H; Douez C; El Ouadi Y
Microb Pathog; 2018 Feb; 115():138-145. PubMed ID: 29253598
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition.
Chen D; Cai J; Cheng J; Jing C; Yin J; Jiang J; Peng Z; Hao X
Sci Rep; 2015 Oct; 5():14972. PubMed ID: 26443922
[TBL] [Abstract][Full Text] [Related]
18. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells.
Govindaraju K; Ingels A; Hasan MN; Sun D; Mathieu V; Masi M; Evidente A; Kornienko A
Bioorg Med Chem Lett; 2018 Feb; 28(4):589-593. PubMed ID: 29409754
[TBL] [Abstract][Full Text] [Related]
19. Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis.
Liu J; Hu WX; He LF; Ye M; Li Y
FEBS Lett; 2004 Dec; 578(3):245-50. PubMed ID: 15589827
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids.
Nair JJ; van Staden J
Nat Prod Commun; 2012 Jul; 7(7):959-62. PubMed ID: 22908593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
